Suppr超能文献

评估外周动脉疾病患者死亡与 CHA2DS2-VASc 评分之间的关系。

Assessment of the relationship between death and CHA2DS2-VASc score in peripheral artery disease.

机构信息

Department of Cardiology, Faculty of Medicine, Afyonkarahisar Health Science University, Afyonkarahisar, Turkey -

Department of Cardiovascular Surgery, University Hospital of Health Sciences Higher Specialization Training and Research of Bursa, Bursa, Turkey.

出版信息

Int Angiol. 2020 Dec;39(6):509-516. doi: 10.23736/S0392-9590.20.04498-3. Epub 2020 Nov 3.

Abstract

BACKGROUND

The CHA2DS2-VASc (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, previous stroke, vascular disease, age 65-74 years, female gender) score is used to estimate thromboembolic risk in atrial fibrillation (AF). Current studies have shown that CHA2DS2-VASc score can predict adverse clinical outcomes in coronary artery disease, stroke, and many diseases irrespective of the presence of AF. The usefulness of CHA2DS2-VASc score in predicting mortality of peripheral arterial disease (PAD) patients is unknown. In this study, we aimed to evaluate the predictive value of the CHA2DS2-VASc score for mortality of PAD patients.

METHODS

A total of 396 patients diagnosed with PAD for the first time in our clinic between January 2010-July 2016 were included in this study. Patients were divided into two groups as deceased (group 1, N.=153) and living (group 2, N.=243). A ROC analysis was performed to determine if CHA2DS2VASc score could predict the death events among PAD patients. Kaplan-Meier analysis was used to evaluate the timing of death events in the two groups.

RESULTS

The mean ages of group 1 and group 2 were 76.6±0.81 and 66.5±0.83 (P=0.007), respectively. The CHA2DS2VASc scores of group-1 (4.37±0.1) and group 2 (2.96±0.9) were significantly different (P<0.001). A significant correlation between CHA2DS2VASc score and death was determined in Spearman correlation (R:0.454, P<0.001). According to multivariate cox regression analysis, CHA2DS2-VASc score [odds ratio (OR): 1.81 (95% CI: 1.42-2.30); P<0.001], Stroke [OR: 0.43 (95% CI: 0.21-0.85); P=0.016] and CRP [OR: 1.04 (95% CI: 1.01-1.06); P=0.002] were independent predictors of death.

CONCLUSIONS

The CHA2DS2VASc score is directly related with mortality in PAD patients. The CHA2DS2VASc score may be a useful and practical scoring method to identify high-risk patients, and further future studies are needed to assess the role of CHA2DS2VASc score in PAD.

摘要

背景

CHA2DS2-VASc(充血性心力衰竭、高血压、年龄≥75 岁、糖尿病、既往卒中、血管疾病、65-74 岁、女性)评分用于估计心房颤动(AF)中的血栓栓塞风险。目前的研究表明,CHA2DS2-VASc 评分可预测冠心病、卒中和许多疾病的不良临床结局,而不论是否存在 AF。CHA2DS2-VASc 评分在预测外周动脉疾病(PAD)患者死亡率中的作用尚不清楚。本研究旨在评估 CHA2DS2-VASc 评分对外周动脉疾病患者死亡率的预测价值。

方法

共纳入 2010 年 1 月至 2016 年 7 月在我院首次诊断为 PAD 的 396 例患者,将患者分为两组:死亡组(组 1,N=153)和存活组(组 2,N=243)。采用 ROC 分析判断 CHA2DS2VASc 评分是否能预测 PAD 患者的死亡事件。Kaplan-Meier 分析用于评估两组患者死亡事件的时间。

结果

组 1 和组 2 的平均年龄分别为 76.6±0.81 岁和 66.5±0.83 岁(P=0.007)。组 1(4.37±0.1)和组 2(2.96±0.9)的 CHA2DS2VASc 评分差异有统计学意义(P<0.001)。Spearman 相关性分析显示 CHA2DS2VASc 评分与死亡之间存在显著相关性(R:0.454,P<0.001)。多变量 Cox 回归分析显示,CHA2DS2-VASc 评分[比值比(OR):1.81(95%置信区间:1.42-2.30);P<0.001]、卒中(OR:0.43(95%置信区间:0.21-0.85);P=0.016)和 CRP(OR:1.04(95%置信区间:1.01-1.06);P=0.002)是死亡的独立预测因素。

结论

CHA2DS2VASc 评分与 PAD 患者的死亡率直接相关。CHA2DS2VASc 评分可能是一种有用且实用的评分方法,可用于识别高危患者,需要进一步的未来研究来评估 CHA2DS2VASc 评分在 PAD 中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验